Jing-Yu Deng1, Dan Sun, Xiang-Yu Liu, Yi Pan, Han Liang. 1. Department of Gastric Oncology Division, Tianjin Medical University Cancer Hospital and City Key Laboratory of Tianjin Cancer Center, Tianjin 300060, China. dengery@sohu.com
Abstract
AIM: To investigate the correlation between gastric cancer growth and signal transducer and activator of transcription-3 (STAT3) expression. METHODS: We assessed the expressions of STAT3, phosphor-STAT3 (pSTAT3), suppressor of cytokine signaling-1 (SOCS-1), survivin and Bcl-2 in gastric cancer patients after gastrectomy by immunohistochemical method. In addition, in situ hybridization was used to further demonstrate the mRNA expression of STAT3 in gastric cancer. RESULTS: With the univariate analysis, expressions of STAT3, pSTAT3, SOCS-1, survivin and Bcl-2, the size of primary tumor and the lymph node metastasis were found to be associated with the overall survival (OS) of gastric cancer patients. However, only pSTAT3 expression and the lymph node metastasis were identified as the independent factors of OS of gastric cancer with multivariate analysis. STAT3 expression was correlated with the lymph node metastasis. There were positive correlations between expressions of STAT3, survivin, Bcl-2 and pSTAT3 in gastric cancer, whereas there was negative correlation between STAT3 expression and SOCS-1 expression in gastric cancer. CONCLUSION: STAT3 can transform into pSTAT3 to promote the survival and inhibit the apoptosis of gastric cancer cells. SOCS-1 might be the valid molecular antagonist to inhibit the STAT3 expression in gastric cancer.
AIM: To investigate the correlation between gastric cancer growth and signal transducer and activator of transcription-3 (STAT3) expression. METHODS: We assessed the expressions of STAT3, phosphor-STAT3 (pSTAT3), suppressor of cytokine signaling-1 (SOCS-1), survivin and Bcl-2 in gastric cancerpatients after gastrectomy by immunohistochemical method. In addition, in situ hybridization was used to further demonstrate the mRNA expression of STAT3 in gastric cancer. RESULTS: With the univariate analysis, expressions of STAT3, pSTAT3, SOCS-1, survivin and Bcl-2, the size of primary tumor and the lymph node metastasis were found to be associated with the overall survival (OS) of gastric cancerpatients. However, only pSTAT3 expression and the lymph node metastasis were identified as the independent factors of OS of gastric cancer with multivariate analysis. STAT3 expression was correlated with the lymph node metastasis. There were positive correlations between expressions of STAT3, survivin, Bcl-2 and pSTAT3 in gastric cancer, whereas there was negative correlation between STAT3 expression and SOCS-1 expression in gastric cancer. CONCLUSION:STAT3 can transform into pSTAT3 to promote the survival and inhibit the apoptosis of gastric cancer cells. SOCS-1 might be the valid molecular antagonist to inhibit the STAT3 expression in gastric cancer.
Authors: Robert Rottapel; Subburaj Ilangumaran; Christopher Neale; Jose La Rose; Jenny M-Y Ho; Melody H-H Nguyen; Dwayne Barber; Patrice Dubreuil; Paulo de Sepulveda Journal: Oncogene Date: 2002-06-27 Impact factor: 9.867
Authors: Zuyao Ni; Wei Lou; Soo Ok Lee; Rajiv Dhir; Fernando DeMiguel; Jennifer Rubin Grandis; Allen C Gao Journal: J Urol Date: 2002-04 Impact factor: 7.450
Authors: Jingyu Deng; Jingli Cui; Nan Jiang; Rupeng Zhang; Li Zhang; Xishan Hao; Han Liang Journal: Am J Transl Res Date: 2014-11-22 Impact factor: 4.060
Authors: Ashleigh R Poh; Amy R Dwyer; Moritz F Eissmann; Ashwini L Chand; David Baloyan; Louis Boon; Michael W Murrey; Lachlan Whitehead; Megan O'Brien; Clifford A Lowell; Tracy L Putoczki; Fiona J Pixley; Robert J J O'Donoghue; Matthias Ernst Journal: Cancer Immunol Res Date: 2020-01-28 Impact factor: 11.151